Animal testing is costly, slow, and poorly predictive. ORIVA offers a human-relevant alternative with the potential to change that.

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...

Insight Molecular Diagnostics Inc. is rated Hold due to upcoming catalysts & pending FDA submission for GraftAssureDx. Read ...

MAS has proposed its new AI Risk Management Guidelines (AIRG), creating a comprehensive framework for the financial sector.

There is no doubt artificial intelligence (AI) has the potential to improve access to mental health care. “One could imagine ...

Schizophrenia, a psychiatric disorder that affects how a person feels, thinks, and behaves, affects roughly 1% of the population (approximately 3.5 million people in the U.S.) and is a leading cause ...

The trends from Bihar’s vote count have thrown the spotlight on the NDA’s calibrated, data-led campaign architecture—and at ...

With a three-year, $1.6 million grant from the U.S. Department of Energy, the University of Nebraska–Lincoln’s Chi Zhang, ...

Businesses face rising email threats; MSPs help implement DMARC and DKIM to prevent spoofing, phishing, and data breaches.

Litigation over the Mariana disaster in Brazil was overshadowed by tension between Pogust Goodhead and its backer ...